.C0151636	ENSP00000280155@inh ENSP00000316244@inh ENSP00000276198@inh ENSP00000347754@inh	cause not known
.C0032708	ENSP00000374467 ENSP00000316136@inh ENSP00000316136	cause not known
C2937350	ENSP00000270349	dopamine transporter is associated with premature ejaculation	http://www.ncbi.nlm.nih.gov/pubmed/20141587
.C0006384	ENSP00000276198 ENSP00000261707 ENSP00000306490 ENSP00000327652 ENSP00000306129 ENSP00000276198@inh	cause not known
C0424448	ENSP00000327652 ENSP00000306129	mask-like faces are a symptom of Parkinson's disease, which involved the dopaminergic system
C0235238	ENSP00000255380@inh	CHRM3 receptors are in ciliary muscles, blockade leads to cycloplegia http://www.ncbi.nlm.nih.gov/pubmed/11181424
C0085281	ENSP00000369237@inh ENSP00000369237	NE has been implicated in addiction	http://www.ncbi.nlm.nih.gov/pubmed/17164822
.C0175167	ENSP00000231509@act	cause not known
C0442886	ENSP00000231509@act	glucocorticoid stimulation decreases inflammation and hence immune response	http://www.ncbi.nlm.nih.gov/pubmed/20159617
C1688637	ENSP00000368766@inh	Intraoperative Floppy Iris Syndrome is caused by an relaxation of the iris dilator muscle	http://www.ncbi.nlm.nih.gov/pubmed/16950249
.C0035410	ENSP00000273430@inh	cause not known
.C0002871	ENSP00000287820@act	cause not known
.C0013604	ENSP00000306662@inh	cause not known
!C0042514	ENSP00000316244@act	"Activation of 5-HT(1A) receptors attenuates tachycardia induced by restraint stress in rats."	http://www.ncbi.nlm.nih.gov/pubmed/17959705
C0151664	ENSP00000354612@inh	related to ulcers
.C0037763	ENSP00000367959	cause not known
.C0026205	ENSP00000280155	cause not known
C0854467	ENSP00000396704 ENSP00000396704@inh	effects of TOP2 inhibitors on bone marrow cells have been shown	http://www.ncbi.nlm.nih.gov/pubmed/8289477
.C0575081	ENSP00000261707	cause not known
.C0039231	ENSP00000276198	cause not known
?C0235259	ENSP00000231509	glucocorticoid receptors are implicated in cataracts, but the exact mechanism is still unclear	http://online.liebertpub.com/doi/abs/10.1089/jop.2006.0067
?C0028084	ENSP00000276198	"Pharmacological agents affecting the neurotransmitters norepinephrine, serotonin and dopamine are clearly associated with patient reports of nightmares."	http://www.ncbi.nlm.nih.gov/pubmed/12532316
C0234047	ENSP00000261707	"SERT(-/-) had lower basal ejaculation frequencies"	http://www.ncbi.nlm.nih.gov/pubmed/20704641
C0020649	ENSP00000276198	serotonin 2 receptors have been implicated in hypotension	http://www.ncbi.nlm.nih.gov/pubmed/3346054
C0020651	ENSP00000276198	serotonin 2 receptors have been implicated in hypotension	http://www.ncbi.nlm.nih.gov/pubmed/3346054
?C0030662	ENSP00000306129@act ENSP00000176183@act ENSP00000373169@act	dopamine agonists have been implicated in pathological gambling	http://www.ncbi.nlm.nih.gov/pubmed/17013907
.C0376297	ENSP00000347046@inh ENSP00000347046	cause not known
.C0011253	ENSP00000261707 ENSP00000276198 ENSP00000367959	cause not known
?C0030446	ENSP00000255380 ENSP00000409378	muscarinic agonists are used to treat ileus	http://www.ncbi.nlm.nih.gov/pubmed/19884293
.C0221185	ENSP00000300900	cause not known
*C0553548	ENSP00000300900	"Systemic hypersensitivity reactions include vasculitis and necrotizing angiitis." (furosemide label)
-C0027849	ENSP00000261707@inh	caused via dopaminergic mechanisms (which have also a lower p-value)
-C0085605	ENSP00000354612 ENSP00000354612@inh ENSP00000356438@inh	unspecific hepatotoxic effect not related to primary target
.C0152198	ENSP00000261707 ENSP00000261707@inh	cause not known
*C0002878	ENSP00000356438 ENSP00000356438@inh ENSP00000354612 ENSP00000354612@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pubmed/3547002
*C0002874	ENSP00000356438 ENSP00000356438@inh ENSP00000354612 ENSP00000354612@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pubmed/3547002
C0152032	ENSP00000255380@inh	urine retention has been found in (male) CHRM3 KO mice	http://www.ncbi.nlm.nih.gov/pubmed/10944224
.C0040485	ENSP00000261707 ENSP00000367959 ENSP00000276198 ENSP00000176183 ENSP00000306490	cause not known
C0242350	ENSP00000276198	HTR2C is involved in erecetion and ejaculation	http://www.ncbi.nlm.nih.gov/pubmed/15488546
C1112442	ENSP00000261707 ENSP00000261707@inh	related to prolactin increase, which is seems to be mediated by serotonin transporter inhibition	http://www.ncbi.nlm.nih.gov/pubmed/10867985 http://www.ncbi.nlm.nih.gov/pubmed/16217346
C2225524	ENSP00000261707 ENSP00000261707@inh	related to prolactin increase, which is seems to be mediated by serotonin transporter inhibition	http://www.ncbi.nlm.nih.gov/pubmed/10867985
.C2584688	ENSP00000369237@inh ENSP00000369237	cause not known	
.C0007398	ENSP00000276198 ENSP00000358301@inh ENSP00000358301	cause not known
-C0553721	ENSP00000306490	related to CHRM3	http://www.ncbi.nlm.nih.gov/pubmed/1888990
C0553721	ENSP00000255380	sweat response is mediated via CHRM3	http://www.ncbi.nlm.nih.gov/pubmed/1888990
C2937350	ENSP00000276198@inh	"A hypothesis of the role of 5-HT1A and 5-HT2C receptors in premature ejaculation is postulated."	http://www.ncbi.nlm.nih.gov/pubmed/9638953
.C0013390	ENSP00000261707 ENSP00000276198@inh ENSP00000276198	cause not known
?C0234022	ENSP00000261707	serotonin has been implicated in sexual functionining via peripheral serotonin receptors	http://www.ncbi.nlm.nih.gov/pubmed/11150571
?C0021177	ENSP00000367959	serotonin has been implicated in sexual functionining via peripheral serotonin receptors	http://www.ncbi.nlm.nih.gov/pubmed/11150571
C0151818	ENSP00000354859@inh ENSP00000373169@inh ENSP00000176183@inh ENSP00000373169 ENSP00000306129@inh	related to extrapyramidal side effects (EPS)
C0600097	ENSP00000347299 ENSP00000347299@inh	"H1 receptor antagonists, are well known to exert sedative effects in humans"	http://www.ncbi.nlm.nih.gov/pubmed/8008209
C0600097	ENSP00000280155 ENSP00000386069 ENSP00000387281	"It is well established that alpha 2-adrenoceptor agonists have sedative and antinociceptive properties."	http://www.ncbi.nlm.nih.gov/pubmed/7916451
C0038587	ENSP00000394624 ENSP00000394624@act ENSP00000265572 ENSP00000265572@act	activation is known to cause physical dependence, and withdrawal symptoms are a consequence	http://www.ncbi.nlm.nih.gov/pubmed/18443637
C1510472	ENSP00000394624 ENSP00000394624@act ENSP00000265572 ENSP00000265572@act	activation is known to cause physical dependence	http://www.ncbi.nlm.nih.gov/pubmed/18443637
C0235063	ENSP00000394624 ENSP00000394624@act ENSP00000265572 ENSP00000265572@act	activation is known to cause respiratory depression	http://www.ncbi.nlm.nih.gov/pubmed/18443637
C0600097	ENSP00000265572 ENSP00000265572@act	activation is known to cause sedation	http://www.ncbi.nlm.nih.gov/pubmed/18443637
.C0034068	ENSP00000290866@inh ENSP00000290866	cause not known
C0085616	ENSP00000313661@act ENSP00000358963@act	"Intrinsic vasoactive substances, such as serotonin and acetylcholine, are known to provoke coronary artery spasm"	http://www.ncbi.nlm.nih.gov/pubmed/9034644
C0010073	ENSP00000313661@act ENSP00000358963@act	"Intrinsic vasoactive substances, such as serotonin and acetylcholine, are known to provoke coronary artery spasm"	http://www.ncbi.nlm.nih.gov/pubmed/9034644
C0040479	ENSP00000262186	well-known side effect of hERG channels	http://www.ncbi.nlm.nih.gov/pubmed/18616963
C0233477	ENSP00000265572@act	dysphoria can be caused by activating the kappa opioid system	http://www.ncbi.nlm.nih.gov/pubmed/18184783
.C0152459	ENSP00000231509	cause not known
?C0241934	ENSP00000261707@inh	case reports and weak statistical signal	http://www.sciencedirect.com/science/article/pii/S0165032711002849 http://neuro.psychiatryonline.org/article.aspx?articleid=179845
.C0267410	ENSP00000358301@inh ENSP00000343782 ENSP00000305372 ENSP00000358301 ENSP00000305372@inh	cause not known
C0034734	ENSP00000358301@inh ENSP00000305372 ENSP00000305372@inh ENSP00000358301 ENSP00000343782	adrenergic mechanisms have been implicated	http://vmj.sagepub.com/content/10/4/293.full.pdf
.C0236071	ENSP00000289753 ENSP00000337949 ENSP00000306129@inh ENSP00000307766 ENSP00000358963 ENSP00000316244 ENSP00000327652@inh ENSP00000373169@inh ENSP00000176183@inh ENSP00000176183 ENSP00000354859@inh ENSP00000367959 ENSP00000306129 ENSP00000313661 ENSP00000373169 ENSP00000287907 ENSP00000327652 ENSP00000301974 ENSP00000280155 ENSP00000276198 ENSP00000386069 ENSP00000347299 ENSP00000387281 ENSP00000354859 ENSP00000306662 ENSP00000367959@inh ENSP00000347754 ENSP00000258400 ENSP00000261707 ENSP00000316244@inh ENSP00000331108 ENSP00000306490 ENSP00000319984 ENSP00000322924 ENSP00000364336 ENSP00000289753@inh ENSP00000369960	cause not known
C0235660	ENSP00000261707	various mechanisms for serotonin-induced galctorrhea have been proposed	http://www.ncbi.nlm.nih.gov/pubmed/14997175
C0006147	ENSP00000261707	various mechanisms for serotonin-induced galctorrhea have been proposed	http://www.ncbi.nlm.nih.gov/pubmed/14997175
C0553731	ENSP00000261707	various mechanisms for serotonin-induced prolactin increase have been proposed	http://www.ncbi.nlm.nih.gov/pubmed/14997175
C0020514	ENSP00000261707	various mechanisms for serotonin-induced prolactin increase have been proposed	http://www.ncbi.nlm.nih.gov/pubmed/14997175
C0221271	ENSP00000354859	EPS are for example manifested in akathasia, which is thought to be caused by D2 blockade	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0221271	ENSP00000367959	EPS are for example manifested in akathasia of SSRI, which is thought to be caused by HTR2A-mediated decrease in dopamine 	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0015371	ENSP00000354859	extrapyramidal syndrome is thought to be caused by D2 blockade	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0234133	ENSP00000354859	EPS are for example manifested in akathasia, which is thought to be caused by D2 blockade	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0234133	ENSP00000367959	EPS are for example manifested in akathasia of SSRI, which is thought to be caused by HTR2A-mediated decrease in dopamine 	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0427086	ENSP00000354859	related to akathasia, which is thought to be caused by D2 blockade	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0700075	ENSP00000354859	related to akathasia, which is thought to be caused by D2 blockade	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0427086	ENSP00000367959	related to akathasia of SSRI, which is thought to be caused by HTR2A-mediated decrease in dopamine 	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0392156	ENSP00000354859	akathasia is thought to be caused by D2 blockade	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0392156	ENSP00000367959	akathasia of SSRI is thought to be caused by HTR2A-mediated decrease in dopamine 	http://www.ncbi.nlm.nih.gov/pubmed/21406165
C0027849	ENSP00000176183 ENSP00000306129 ENSP00000327652 ENSP00000354859 ENSP00000373169 "central dopamine hypoactivity hypothesis is widely accepted as a key element of the pathogenesis of NMS"	http://www.ncbi.nlm.nih.gov/pubmed/20623765
C0392676	ENSP00000306129@inh	related to neuroleptic malignant syndrome	http://www.ncbi.nlm.nih.gov/pubmed/20623765
C0948281	ENSP00000176183 ENSP00000306129 ENSP00000327652 ENSP00000354859 ENSP00000373169 "central dopamine hypoactivity hypothesis is widely accepted as a key element of the pathogenesis of NMS"	http://www.ncbi.nlm.nih.gov/pubmed/20623765
?C0030807	ENSP00000290866@inh ACE inhibitors have been implicated in pemphigus	http://www.ncbi.nlm.nih.gov/pubmed/7967779
C0151564	ENSP00000373169 ENSP00000373169	DRD KO mice have abnormal locomotor behaviour
C0026837	ENSP00000373169 ENSP00000373169	DRD KO mice have abnormal locomotor behaviour
.C0020456	ENSP00000354612	cause not known
!C0026826	ENSP00000276198@inh	HTR2C KO mice show hypotonia
.C0040822	ENSP00000340684	cause not known
C0003578	ENSP00000023897	GABAergic mechanism contribute to some types of apnea	http://www.ncbi.nlm.nih.gov/pubmed/11247962
.C0233565	ENSP00000369237@inh	cause not known
.C0030232	ENSP00000270349	cause not known
?C0032285	ENSP00000356438@inh	cyclooxygenase-2 are involved in the molecular pathogenesis of inflammatory lung diseases http://ajplung.physiology.org/content/290/5/L797.full
.C0020621	ENSP00000387281@inh	cause not known
.C0037763	ENSP00000277010	cause not known
C0027092	ENSP00000306490@act	muscarinic antagonists have been shown to stopping the progression of myopia via M1 and M4	http://www.ncbi.nlm.nih.gov/pubmed/22836762
C0028961	ENSP00000276198	HTR2C KO mice show dehydration
~C0010038	ENSP00000354612@inh ENSP00000354612 ENSP00000356438@inh ENSP00000356438	related to ophthalmic use
.C0497156	ENSP00000261707	cause not known
.C0020456	ENSP00000306129@inh	cause not known
C0027066	ENSP00000369237	NE transporter inactivation influences myoclonic seizures	http://www.ncbi.nlm.nih.gov/pubmed/16052243
!C0020538	ENSP00000280155@inh	adrenergic alpha blockers are indicated against hypertension	http://www.ncbi.nlm.nih.gov/pubmed/1980236
C0004245	ENSP00000328968	numerous cardiac phenotypes are observed for SCN5A KO mice
C0011603	ENSP00000290866	ACE inhibitors modulate dermatitis	http://www.ncbi.nlm.nih.gov/pubmed/12646655
C0546884	ENSP00000290866@inh ENSP00000290866	polyuria and abnormal urine homeostasis are symptoms of ACE mutant mice, leading to decreased blood volume
.C1883552	ENSP00000273430@inh	cause not known
.C0035455	ENSP00000273430@inh	cause not known
?C0027066	ENSP00000367309@inh	anectodal evidence for a connection between serotnin syndrome and MAO inhibitors	http://ajp.psychiatryonline.org/article.aspx?articleid=97932
.C0393593	ENSP00000316244@act	cause not known
.C0004245	ENSP00000347754@inh ENSP00000347754	cause not known
.C0011603	ENSP00000327652@inh ENSP00000306129@inh	cause not known
-C0393593	ENSP00000367309 ENSP00000340684	according to "Drug Induced Movement Disorders", dystonia has not been observed for MAOI
C0040822	ENSP00000328968 ENSP00000328968@inh	sodium channel KO mice show tremors
.C0870082	ENSP00000276198 ENSP00000261707	cause not known
C0151692	ENSP00000231509	Exogenous glucocorticoids are known to inhibit wound repair	http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1084153/
.C0010520	ENSP00000354859@act	cause not known
.C0243026	ENSP00000356438@inh ENSP00000356438 ENSP00000354612 ENSP00000354612@inh	cause not known
!C0002170	ENSP00000356438@inh ENSP00000354612@inh cyclooxygenase overexpression leads to alopecia	http://www.ncbi.nlm.nih.gov/pubmed/11980643
.C0040053	ENSP00000358301@inh ENSP00000358301 ENSP00000305372	cause not known
C0028754	ENSP00000261707	(female) SERT KO mice have increased abdominal fat http://www.nature.com/oby/journal/v18/n1/abs/oby2009139a.html
C0271650	ENSP00000231509@act ENSP00000231509	Glucocorticoids induce insulin resistance in humans	http://www.ncbi.nlm.nih.gov/pubmed/12351424
?C0011603	ENSP00000356438@inh ENSP00000356438 ENSP00000354612@inh ENSP00000354612	skin side effects have been described for NSAIDs	http://www.dermnetnz.org/reactions/nsaids.html
C0019080	ENSP00000354612	PTGS knockout mice have abnormal platelet and blood phenotypes
C0034150	ENSP00000354612	PTGS knockout mice have abnormal platelet and blood phenotypes
C0744727	ENSP00000306662@inh ENSP00000369960@inh	administration of epinephrine increases hematocrit	http://hyper.ahajournals.org/content/25/5/1096.long
C0026961	ENSP00000270349@inh	dopamine is known to cause mydriasis	http://www.iovs.org/content/15/5/371.full.pdf
.C0004245	ENSP00000276198	cause not known
C0027066	ENSP00000270349@inh	connection between NE transporter and seizures known	http://www.ncbi.nlm.nih.gov/pubmed/16052243
C0043096	ENSP00000276198	decreased body weight is a phenotype of HTR2C mutant mice
C0035078	ENSP00000273430 ENSP00000273430@inh	Angiotensin (Ang) II mediates pathophysiologial changes in the kidney.	http://www.ncbi.nlm.nih.gov/pubmed/19404405
C0042514	ENSP00000262186	related to long QT syndrome, a known SE for hERG	http://www.ncbi.nlm.nih.gov/pubmed/22987108
C0004245	ENSP00000262186	related to long QT syndrome, a known SE for hERG	http://www.ncbi.nlm.nih.gov/pubmed/20975234
.C0023380	ENSP00000276198 ENSP00000261707 ENSP00000280155 ENSP00000176183@inh ENSP00000386069 ENSP00000387281 ENSP00000176183 ENSP00000354859@act ENSP00000327652@inh ENSP00000316244 ENSP00000327652 ENSP00000373169@inh	cause not known
C0004245	ENSP00000358301 ENSP00000305372	adrenergic receptors are known to influence AV nodal function	http://www.ncbi.nlm.nih.gov/pubmed/1348976
C0018794	ENSP00000358301 ENSP00000305372	adrenergic receptors are known to influence AV nodal function	http://www.ncbi.nlm.nih.gov/pubmed/1348976
?C0018802	ENSP00000358301 ENSP00000305372	beta blockers have long been seen as counter-indicated in heart failure	http://eurheartj.oxfordjournals.org/content/17/suppl_B/21.full.pdf
C0042514	ENSP00000276198	HT-2 receptors play a role in tachycardia	http://www.ncbi.nlm.nih.gov/pubmed/1702484
~C0018802	ENSP00000356438@inh ENSP00000356438 ENSP00000354612@inh ENSP00000354612 ENSP00000356438@act	labels contain a warning that fluid retention might lead to heart failure
C0476273	ENSP00000358301@inh ENSP00000305372@inh ENSP00000305372 ENSP00000358301 ENSP00000343782	respiratory effects of beta blockers are known	http://www.ncbi.nlm.nih.gov/pubmed/17456025
C0004134	ENSP00000023897 ENSP00000274547 ENSP00000299267	GABA Transporter Deficiency Causes Ataxia	http://www.ncbi.nlm.nih.gov/pubmed/15788781
!C0027121	ENSP00000262735@act	PPAR-alpha deficient mice have prolonged inflammation response http://www.ncbi.nlm.nih.gov/pubmed/8900274
!C0032617	ENSP00000316244@act	Serotonin 5-HT(1A)receptor agonist 8-OH DPAT suppressed drinking behavior in rats. http://www.ncbi.nlm.nih.gov/pubmed/11550043
!C0043094	ENSP00000258400	HTR2B knockout mice have decreased body weight
!C0043094	ENSP00000356438@inh	decreased body weight is a phenotype of PTGS2 mutant mice
!C0043094	ENSP00000369237@inh	decreased body weight is a phenotype of SLC6A2 mutant mice
!C0043094	ENSP00000276198@inh	decreased body weight is a phenotype of HTR2 mutant mice
!C0043094	ENSP00000258400@inh	decreased body weight is a phenotype of HTR2 mutant mice
*C0151626	ENSP00000356438 ENSP00000356438@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pubmed/2961055
*C0014742	ENSP00000356438 ENSP00000356438@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pubmed/2961055
*C0011606	ENSP00000356438 ENSP00000356438@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pubmed/2961055
*C0014518	ENSP00000356438@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pubmed/2961055
*C0025290	ENSP00000356438@inh	thought to be a hypersensitivity reaction	http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1306340/
*C0036416	ENSP00000349078	thought to be a reaction to bisphosphonates mediated via immune system	http://www.ncbi.nlm.nih.gov/pubmed/16108245
-C0004095	ENSP00000359793@act	most likely due to topical administration as eye drops of prostaglandin analogs
-C0022081	ENSP00000359793@act	most likely due to topical administration as eye drops of prostaglandin analogs
-C0022568	ENSP00000359793@act	most likely due to topical administration as eye drops of prostaglandin analogs
-C0033117	ENSP00000261707@inh ENSP00000306129@act	probably mediated via adrenergic receptors
-C0042164	ENSP00000359793@act	most likely due to topical administration as eye drops of prostaglandin analogs
-C0152227	ENSP00000359793@act	most likely due to topical administration as eye drops of prostaglandin analogs
-C0235267	ENSP00000359793@act	most likely due to topical administration as eye drops of prostaglandin analogs
-C0242429	ENSP00000176183@inh	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000222982@act	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000337450@act	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000337915@act	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000280155@inh	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000373169@inh	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000368766@inh	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000306662@inh	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000387281@inh	secondary SE caused by infections due to agranulocytosis
-C0242429	ENSP00000369960@inh	secondary SE caused by infections due to agranulocytosis
.C0011175	ENSP00000261707	cause not known
.C0011880	ENSP00000287907@act	cause not known
.C0011880	ENSP00000316244@act	cause not known
.C0013604	ENSP00000316244	cause not known
.C0015695	ENSP00000289753	cause not known
.C0019158	ENSP00000354612	cause not known
.C0019158	ENSP00000356438	cause not known
.C0020514	ENSP00000367959	cause not known
.C0022104	ENSP00000354859@act	cause not known
.C0022346	ENSP00000228858	cause not known
.C0022346	ENSP00000261707@inh	cause not known
.C0022346	ENSP00000354612@inh	cause not known
.C0023067	ENSP00000358963@act	cause not known
.C0025289	ENSP00000354612	cause not known
.C0025289	ENSP00000356438	cause not known
.C0025874	ENSP00000206249@act	cause not known
.C0027424	ENSP00000276198	cause not known
.C0027769	ENSP00000313661@act	cause not known
.C0032617	ENSP00000369237	cause not known
.C0032708	ENSP00000274629	cause not known
.C0035078	ENSP00000295897	cause not known
.C0035334	ENSP00000373169@inh	a mechanism for pigmentary retinopathy involving dopamine receptor blockade has been proposed: http://www.ncbi.nlm.nih.gov/pubmed/12152801
.C0037036	ENSP00000313661	cause not known
.C0037672	ENSP00000354859@act	cause not known
.C0042420	ENSP00000354859@act	cause not known
.C0242461	ENSP00000305372@inh ENSP00000358301@inh	cause not known
.C0162835	ENSP00000231509	cause not known
.C0241353	ENSP00000369237@inh	cause not known
.C0314719	ENSP00000261707	cause not known
.C0314719	ENSP00000289753	cause not known
.C0314719	ENSP00000358963@act	cause not known
?C0002170	ENSP00000261707@inh	alopecia has been recognized as a rare side effect of SSRIs	http://www.ncbi.nlm.nih.gov/pubmed/16783834 
?C0003873	ENSP00000261707@inh	treatment with SSRI has been shown to speed up arthritic inflammation	http://www.ncbi.nlm.nih.gov/pubmed/9825746
?C0006325	ENSP00000261707@inh	bruxism has been described as SSRI-induced http://www.ncbi.nlm.nih.gov/pubmed/10665633
?C0006325	ENSP00000373169@act	Hypersensitive presynaptic dopamine receptors have been implicated in bruxism http://www.ncbi.nlm.nih.gov/pubmed/15749418
?C0006325	ENSP00000369960	bruxism is reduced by alpha adrenergic agonism http://www.ncbi.nlm.nih.gov/pubmed/16553016
?C0010692	ENSP00000354612	NSAIDs are known to be associated with nonbacterial cystitits	http://www.arhp.org/Publications-and-Resources/Clinical-Proceedings/Screening-Treatment-and-Management-of-ICPBS/Diagnosis
?C0010692	ENSP00000356438	NSAIDs are known to be associated with nonbacterial cystitits	http://www.arhp.org/Publications-and-Resources/Clinical-Proceedings/Screening-Treatment-and-Management-of-ICPBS/Diagnosis
?C0011124	ENSP00000261707	SSRI-Associated Sexual Dysfunction has been described, but cause is unclear	http://ajp.psychiatryonline.org/cgi/content/full/163/9/1504
?C0011570	ENSP00000358301@inh	the association of mental depression and beta blockers has been disputed, connection unclear http://www.ncbi.nlm.nih.gov/pubmed/12117400
?C0011570	ENSP00000305372@inh	the association of mental depression and beta blockers has been disputed, connection unclear http://www.ncbi.nlm.nih.gov/pubmed/12117400
?C0011570	ENSP00000343782@inh	the association of mental depression and beta blockers has been disputed, connection unclear http://www.ncbi.nlm.nih.gov/pubmed/12117400
?C0011616	ENSP00000261707	the serotonin system contributes to contact dermatitis http://www.ncbi.nlm.nih.gov/pubmed/17721644
?C0015672	ENSP00000369237	NE reuptake inhibitors have been proposed to treat "chronic fatigue syndrome" and Fibromyalgia (symptome: fatigue)	http://www.ncbi.nlm.nih.gov/pubmed/18537652	http://www.ncbi.nlm.nih.gov/pubmed/18336891
?C0020565	ENSP00000261707	breast enlargement has been linked to SSRI, but mechanism is unknown, potentially via dopaminergic system	http://www.ncbi.nlm.nih.gov/pubmed/9479619
?C0021116	ENSP00000367959	serotonin receptors are involved in penile tissue contraction	http://www.ncbi.nlm.nih.gov/pubmed/12934054
?C0021116	ENSP00000367959@inh	serotonin receptors are involved in penile tissue contraction	http://www.ncbi.nlm.nih.gov/pubmed/12934054
?C0021116	ENSP00000261707	SSRI-Associated Sexual Dysfunction has been described, but cause is unclear	http://ajp.psychiatryonline.org/cgi/content/full/163/9/1504
?C0021141	ENSP00000261707	SIADH has been linked to SSRIs, but no mechanism is known	http://www.ncbi.nlm.nih.gov/pubmed/8804257
C0027707	ENSP00000354612@inh ENSP00000356438@inh ENSP00000356438 ENSP00000354612	PTGS1/2 knockout mice have kidney deformities and NSAIDs are implicated in analgesic nephropathy	http://www.ncbi.nlm.nih.gov/pubmed/MeSH
C0027726	ENSP00000354612@inh ENSP00000356438@inh ENSP00000356438 ENSP00000354612	PTGS1/2 knockout mice have kidney deformities and NSAIDs are implicated in analgesic nephropathy	http://www.ncbi.nlm.nih.gov/pubmed/MeSH
C0022667	ENSP00000354612@inh ENSP00000356438@inh ENSP00000356438 ENSP00000354612	PTGS1/2 knockout mice have kidney deformities and NSAIDs are implicated in analgesic nephropathy	http://www.ncbi.nlm.nih.gov/pubmed/MeSH
?C0030193	ENSP00000270349	dopamine reuptake inh. have been shown to be analgesic	http://www.ncbi.nlm.nih.gov/pubmed/11706096
?C0030305	ENSP00000356438@inh	there is a risk for acute pancreatitis patients taking NSAIDs	http://www.mdpi.com/1424-8247/3/3/558/
?C0032708	ENSP00000206249	Oral contraceptives and postmenopausal estrogen replacement therapy are recognized as risk factors for the development of porphyria cutanea tarda (PCT) in women. http://www.ncbi.nlm.nih.gov/pubmed/11128750
?C0033117	ENSP00000368766@inh	alpha 1 blockade is a proposed mechanism of action for priapism	http://www.ncbi.nlm.nih.gov/pubmed/11939691
?C0033117	ENSP00000306662@inh	alpha 1 blockade is a proposed mechanism of action for priapism	http://www.ncbi.nlm.nih.gov/pubmed/11939691
?C0033117	ENSP00000369960@inh	alpha 1 blockade is a proposed mechanism of action for priapism	http://www.ncbi.nlm.nih.gov/pubmed/11939691
?C0033117	ENSP00000369960@inh	thought to be related to alpha adrenergic blockade http://www.ncbi.nlm.nih.gov/pubmed/18090503
?C0033117	ENSP00000368766@inh	thought to be related to alpha adrenergic blockade http://www.ncbi.nlm.nih.gov/pubmed/18090503
?C0033117	ENSP00000306662@inh	thought to be related to alpha adrenergic blockade http://www.ncbi.nlm.nih.gov/pubmed/18090503
?C0033117	ENSP00000280155@inh	thought to be related to alpha adrenergic blockade http://www.ncbi.nlm.nih.gov/pubmed/18090503
?C0033117	ENSP00000387281@inh	thought to be related to alpha adrenergic blockade http://www.ncbi.nlm.nih.gov/pubmed/18090503
?C0040822	ENSP00000261707	tremors are recognized as most common movement disorder of SSRI http://www.ncbi.nlm.nih.gov/pubmed/16297844 loss of serotonin transporters is correlated with onset of tremors in Parkinson's disease http://www.ncbi.nlm.nih.gov/pubmed/18335163
?C0042024	ENSP00000367959	the serotonergic system is implicated in bladder voiding	http://www.ncbi.nlm.nih.gov/pubmed/11264473
?C0080274	ENSP00000261707	both the adrenergic and serotonergic system are implicated in bladder voiding	http://www.ncbi.nlm.nih.gov/pubmed/11264473
?C0080274	ENSP00000369237	both the adrenergic and serotonergic system are implicated in bladder voiding	http://www.ncbi.nlm.nih.gov/pubmed/11264473
?C0151798	ENSP00000290866@inh	Hepatotoxicity is known to be associated with angiotensin-converting enzyme inhibitors http://www.ncbi.nlm.nih.gov/pubmed/8292107
?C0151825	ENSP00000313661@act	perhaps related to hyperesthesia which we showed to be caused by HTR7 receptors
?C0151827	ENSP00000313661@act	perhaps related to hyperesthesia which we showed to be caused by HTR7 receptors
?C0376356	ENSP00000343877	PMS Premenstrual syndrome (PMS) appears to be caused e.g. by fluctuations in levels of circulating estrogen and progesterone	http://www.merck.com/mmpe/sec18/ch244/ch244g.html
?C0376356	ENSP00000343877@act	PMS Premenstrual syndrome (PMS) appears to be caused e.g. by fluctuations in levels of circulating estrogen and progesterone	http://www.merck.com/mmpe/sec18/ch244/ch244g.html
C0000729	ENSP00000354612	related to ulcers
C0000729	ENSP00000356438	related to ulcers
C0151971	ENSP00000354612 ENSP00000354612@inh ENSP00000356438@inh ENSP00000356438	prostaglandins are known to be involved in gastric mucosal protection	http://www.ncbi.nlm.nih.gov/pubmed/18923189
C0000768	ENSP00000373169@act	dopamine agonists cause fetal malformations in rabbits, which increase in incidence when levodopa is administered concurrently http://www.gsk.com.au/resources.ashx/prescriptionmedicinesproductschilddataproinfo/880/FileName/C044FA5B6DD9B417F6B344DAA4F1E58F/PI_Repreve.pdf
C0001824	ENSP00000354612	PTGS knockout mice have abnormal platelet and blood phenotypes
C0001824	ENSP00000356438	PTGS knockout mice have abnormal platelet and blood phenotypes
C0002063	ENSP00000370381@inh	highly similar protein SLC12A2 causes alkalosis http://www.ncbi.nlm.nih.gov/pubmed/8640224
C0002063	ENSP00000370381	mutations in the Na-K-Cl cotransporter cause hereditary alkalosis	http://www.ncbi.nlm.nih.gov/pubmed/8640224
C0002170	ENSP00000358301@inh	hair follicles are known to contain beta receptors, beta blockers cause hair loss, beta agonists accelerate hair cycle http://www.ncbi.nlm.nih.gov/pubmed/10594725 http://www.ncbi.nlm.nih.gov/pubmed/11152763
C0002170	ENSP00000305372@inh	hair follicles are known to contain beta receptors, beta blockers cause hair loss, beta agonists accelerate hair cycle http://www.ncbi.nlm.nih.gov/pubmed/10594725 http://www.ncbi.nlm.nih.gov/pubmed/11152763
C0002170	ENSP00000343782@inh	hair follicles are known to contain beta receptors, beta blockers cause hair loss, beta agonists accelerate hair cycle http://www.ncbi.nlm.nih.gov/pubmed/10594725 http://www.ncbi.nlm.nih.gov/pubmed/11152763
C0002453	ENSP00000354859@inh	linked to remove of dopaminergic prolactin inhibition http://books.google.com/books?id=vOQqyNhTDl0C&lpg=PA895&ots=LqXPl2j5_1&dq=gynecomastia%20dopamine&pg=PA896#v=onepage&q=gynecomastia%20dopamine&f=false http://www.ncbi.nlm.nih.gov/pubmed/11739329
C0006147	ENSP00000354859@inh	linked to remove of dopaminergic prolactin inhibition http://books.google.com/books?id=vOQqyNhTDl0C&lpg=PA895&ots=LqXPl2j5_1&dq=gynecomastia%20dopamine&pg=PA896#v=onepage&q=gynecomastia%20dopamine&f=false http://www.ncbi.nlm.nih.gov/pubmed/11739329
C0002871	ENSP00000356438@inh	gastrointestinal lesions, which are seen in mutant mice, can cause bleeding leading to anemia	http://www.ncbi.nlm.nih.gov/pubmed/8179652
C0003123	ENSP00000387281@inh	activation of alpha 2-adrenoceptors in the hypothalamic paraventricular nucleus increases eating	http://www.ncbi.nlm.nih.gov/pubmed/11054588
C0003578	ENSP00000394624@act	opioids can decrease deep breathing, thus have an influence on breathing http://www.merck.com/mmhe/sec04/ch048/ch048a.html
C0003578	ENSP00000410732	GABAergic pathways are involved in at least some kinds of apnea	http://www.ncbi.nlm.nih.gov/pubmed/11247962
C0004134	ENSP00000369237@inh	inactivation of the norepinephrine transporter decreases spontaneous locomotor activity	http://www.ncbi.nlm.nih.gov/pubmed/16893531
C0004134	ENSP00000264318	a mutation which increases GABA receptor levels causes ataxia http://www.ncbi.nlm.nih.gov/pubmed/19759851
C0004134	ENSP00000328968@inh	ataxia has been observed as a phenotype in SCN8A mutant mice 
C0004144	ENSP00000265572@act	opioids can decrease deep breathing, leading to atelectasis http://www.merck.com/mmhe/sec04/ch048/ch048a.html
C0004144	ENSP00000394624@act	opioids can decrease deep breathing, leading to atelectasis http://www.merck.com/mmhe/sec04/ch048/ch048a.html
C0004245	ENSP00000353820	ADRB receptor stimulation influences AV node activity	http://www.ncbi.nlm.nih.gov/pubmed/1348976
C0005745	ENSP00000343782@inh	blockade of adrenergic receptors in the eye muscles might lead to blepharoptosis http://www.ncbi.nlm.nih.gov/pubmed/17881986
C0005745	ENSP00000305372@inh	blockade of adrenergic receptors in the eye muscles might lead to blepharoptosis http://www.ncbi.nlm.nih.gov/pubmed/17881986
C0006266	ENSP00000358301@inh	beta (mainly beta2) agonists are used against bronchospams, blockers are known to cause it	http://en.wikipedia.org/wiki/Albuterol	http://www.ncbi.nlm.nih.gov/pubmed/16787801
C0006266	ENSP00000305372@inh	beta (mainly beta2) agonists are used against bronchospams, blockers are known to cause it	http://en.wikipedia.org/wiki/Albuterol	http://www.ncbi.nlm.nih.gov/pubmed/16787801
C0006266	ENSP00000343782@inh	beta (mainly beta2) agonists are used against bronchospams, blockers are known to cause it	http://en.wikipedia.org/wiki/Albuterol	http://www.ncbi.nlm.nih.gov/pubmed/16787801
C0009676	ENSP00000358301@inh	related to hypotension caused by beta blockers
C0009806	ENSP00000358301@act	activation of beta adrenergic receptors in GI tract changes (slows) motility	http://www.ncbi.nlm.nih.gov/pubmed/1600036
C0009806	ENSP00000255380@inh	constipation is known to be mediated by M3 antagonism http://www.ncbi.nlm.nih.gov/pubmed/19168050
C0009806	ENSP00000261707@inh	SLC6A4 mutant mice show a mixed phenotype of diarrhea and constipation http://www.ncbi.nlm.nih.gov/pubmed/11487658
C0009952	ENSP00000373169@inh	dopamine agonists alleviate seizures, whereas dopamine antagonists cause it http://www.ncbi.nlm.nih.gov/pubmed/8787131
C0011168	ENSP00000387281@inh	activation of alpha 2-adrenoceptors in the hypothalamic paraventricular nucleus increases eating http://www.ncbi.nlm.nih.gov/pubmed/11054588
C0013604	ENSP00000288139@inh	edema have been observed in CACNA1S mutant mice
C0015300	ENSP00000261707@inh	serotonin can induce exophthalmos http://www.springerlink.com/content/g071849027021w13/
C0015967	ENSP00000257497	Glucocorticoids induce annexin A1 secretion, which in turn suppresses fever	http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1909025	http://www.nature.com/bjp/journal/v155/n2/full/bjp2008252a.html
C0017152	ENSP00000354612	related to ulcers
C0017152	ENSP00000356438	related to ulcers
C0017181	ENSP00000354612	related to ulcers
C0017181	ENSP00000356438	related to ulcers
C0018418	ENSP00000354859@inh	linked to removal of dopaminergic prolactin inhibition http://books.google.com/books?id=vOQqyNhTDl0C&lpg=PA895&ots=LqXPl2j5_1&dq=gynecomastia%20dopamine&pg=PA896#v=onepage&q=gynecomastia%20dopamine&f=false http://www.ncbi.nlm.nih.gov/pubmed/11739329
C0018418	ENSP00000373169@inh	linked to removal of dopaminergic prolactin inhibition http://books.google.com/books?id=vOQqyNhTDl0C&lpg=PA895&ots=LqXPl2j5_1&dq=gynecomastia%20dopamine&pg=PA896#v=onepage&q=gynecomastia%20dopamine&f=false http://www.ncbi.nlm.nih.gov/pubmed/11739329
C0018524	ENSP00000410732	changes in GABA activity are known to lead to hallucinations	http://www.ncbi.nlm.nih.gov/pubmed/19667317
C0018524	ENSP00000295454	changes in GABA activity are known to lead to hallucinations	http://www.ncbi.nlm.nih.gov/pubmed/19667317
?C0018524	ENSP00000261707	related to serotonin syndrome	http://qjmed.oxfordjournals.org/content/96/9/635.full http://www.ncbi.nlm.nih.gov/pubmed/15784664
C0018681	ENSP00000305372@inh	beta blocker have been used to prevent migraine headaches	http://www.ncbi.nlm.nih.gov/pubmed/16095268
C0018802	ENSP00000288139@inh	calcium channels are involved in cardiac diseases http://www.jci.org/articles/view/27167
C0018802	ENSP00000328968@inh	SCN5A mutations increase the rate of heart failure http://www.ncbi.nlm.nih.gov/pubmed/15671429
C0018926	ENSP00000354612	related to ulcers
C0018926	ENSP00000356438	related to ulcers
?C0019521	ENSP00000313661@act	drugs affecting the serotonin system (both agonists and antagonists) have been used to treat hiccups http://www.ncbi.nlm.nih.gov/pubmed/19555801 http://www.ncbi.nlm.nih.gov/pubmed/15083300
C0020437	ENSP00000343925	estrogen is known to have an effect on calcium concentration http://www.ncbi.nlm.nih.gov/pubmed/17942777
C0020437	ENSP00000343925	estrogen is known to have an effect on calcium concentration http://www.ncbi.nlm.nih.gov/pubmed/17942777
C0020453	ENSP00000313661@act	shown by us to be caused via the related HTR7 receptor
C0020615	ENSP00000357068@inh	calcium channel mutations cause hypoglycemia http://www.ncbi.nlm.nih.gov/pubmed/10449331
C0020621	ENSP00000358301@act	known effect of beta agonists like epinephrine http://www.ncbi.nlm.nih.gov/pubmed/6314140
C0020621	ENSP00000305372@act	known effect of beta agonists like epinephrine http://www.ncbi.nlm.nih.gov/pubmed/6314140
C0020621	ENSP00000343782@act	known effect of beta agonists like epinephrine http://www.ncbi.nlm.nih.gov/pubmed/6314140
C0020649	ENSP00000280155@inh	known SE of alpha blockers http://www.merck.com/mmhe/sec03/ch023/ch023c.html
C0020649	ENSP00000368766@inh	known SE of alpha blockers http://www.merck.com/mmhe/sec03/ch023/ch023c.html
C0020649	ENSP00000306662@inh	known SE of alpha blockers http://www.merck.com/mmhe/sec03/ch023/ch023c.html
C0020649	ENSP00000387281@inh	known SE of alpha blockers http://www.merck.com/mmhe/sec03/ch023/ch023c.html
C0020649	ENSP00000369960@inh	known SE of alpha blockers http://www.merck.com/mmhe/sec03/ch023/ch023c.html
C0020649	ENSP00000358301@inh	beta blocker can increase and decrease heart rate mice depending on the concentration http://www.ncbi.nlm.nih.gov/pubmed/19672458
C0020651	ENSP00000280155@inh	known SE of alpha blockers: Alpha1 blockers inhibit vasoconstriction normally initiated by the baroreceptor reflex upon postural change and the subsequent drop in pressure.	http://www.merckmanuals.com/home/sec03/ch023/ch023c.html
C0020651	ENSP00000368766@inh	known SE of alpha blockers: Alpha1 blockers inhibit vasoconstriction normally initiated by the baroreceptor reflex upon postural change and the subsequent drop in pressure.	http://www.merckmanuals.com/home/sec03/ch023/ch023c.html
C0020651	ENSP00000306662@inh	known SE of alpha blockers: Alpha1 blockers inhibit vasoconstriction normally initiated by the baroreceptor reflex upon postural change and the subsequent drop in pressure.	http://www.merckmanuals.com/home/sec03/ch023/ch023c.html
C0020651	ENSP00000387281@inh	known SE of alpha blockers: Alpha1 blockers inhibit vasoconstriction normally initiated by the baroreceptor reflex upon postural change and the subsequent drop in pressure.	http://www.merckmanuals.com/home/sec03/ch023/ch023c.html
C0020651	ENSP00000369960@inh	known SE of alpha blockers: Alpha1 blockers inhibit vasoconstriction normally initiated by the baroreceptor reflex upon postural change and the subsequent drop in pressure.	http://www.merckmanuals.com/home/sec03/ch023/ch023c.html
C0021390	ENSP00000265572@act	opioid system plays role in IBD: http://www.ncbi.nlm.nih.gov/pubmed/17343284 agonists are predicted to alleviate IBD, but antagonists also do so http://www.ncbi.nlm.nih.gov/pubmed/18569389
C0022346	ENSP00000373169@inh	dopamine has been shown to increase liver blood flow, thus increasing liver function http://ats.ctsnetjournals.org/cgi/content/full/60/6/1741 http://www.ncbi.nlm.nih.gov/pubmed/20137821
C0024586	ENSP00000261707	observed in SLC6A4 mutant mice http://www.ncbi.nlm.nih.gov/pubmed/18209729
C0025160	ENSP00000265572@act	opioids are used as antidiarrhoeal drugs http://www.ncbi.nlm.nih.gov/pubmed/8984506
C0025222	ENSP00000354612	related to ulcers
C0025222	ENSP00000356438@inh	related to ulcers
C0026266	ENSP00000258400	HTR2B knockout mice have a variety of cardiac defects
C0027424	ENSP00000358301@inh	adrenergic agonists are used as nasal decongestants	http://www.elmhurst.edu/~chm/vchembook/663adrenergic2.html
C0030193	ENSP00000316244@act	serotonin 1A receptors have been implicated in hyperalgesia, but serotonin has also analgesic effects. some agonists are hyperalgesic	http://jpet.aspetjournals.org/cgi/content/full/312/3/1034
C0030312	ENSP00000354612	PTGS knockout mice have abnormal platelet and blood phenotypes
C0030312	ENSP00000356438	PTGS knockout mice have abnormal platelet and blood phenotypes
C0030920	ENSP00000354612	Inhibition of COX-1 has been linked to GI adverse effects	http://www.ncbi.nlm.nih.gov/pubmed/19680014
C0032285	ENSP00000290866@inh	a mechanism for the contribution of inhibition of ACE has been proposed http://www.ncbi.nlm.nih.gov/pubmed/17082641
C0032617	ENSP00000276198@inh	polyphagia is a phenotype of HTR2C mice, depletion of serotonin can lead to polydipsia http://books.google.com/books?hl=en&lr=&id=eUfVba3cjI4C&oi=fnd&pg=PA253&dq=polyuria+OR+polydipsia+serotonin+receptor&ots=lJzRMhcPN0&sig=zEs3f4astA_nooJHTDHQxnKYPNE#v=snippet&q=polydipsia&f=false
C0033975	ENSP00000354859@act	dopamine blockers are used as anti-psychotics	http://www.williams.edu/imput/synapse/pages/IIIB5.htm
?C0034063	ENSP00000358301@inh	"Beta-blockers may cause cardiogenic pulmonary edema secondary to their negative inotropic and negative chronotropic effects." http://www.ncbi.nlm.nih.gov/pubmed/7633013
C0034880	ENSP00000316244	HTR1A agonists influence auditory cortex	http://www.ncbi.nlm.nih.gov/pubmed/10633476
C0036572	ENSP00000262186	associated with seizures in Drosophila	http://www.ncbi.nlm.nih.gov/pubmed/8994043
C0037763	ENSP00000394624@act	myoclonus are known SE of opioids http://www.ncbi.nlm.nih.gov/pubmed/18443635
C0037763	ENSP00000354859@inh	thought to be related to blockade of DRD2 while DRD1 is still more active	http://www.ncbi.nlm.nih.gov/pubmed/7969212
C0038362	ENSP00000354612	related to ulcers
C0038362	ENSP00000356438	related to ulcers
?C0038990	ENSP00000261707	related to serotonin syndrome	http://qjmed.oxfordjournals.org/content/96/9/635.full http://www.ncbi.nlm.nih.gov/pubmed/15784664
?C0038990	ENSP00000289753	related to serotonin syndrome	http://qjmed.oxfordjournals.org/content/96/9/635.full http://www.ncbi.nlm.nih.gov/pubmed/15784664
?C0039231	ENSP00000261707	related to serotonin syndrome	http://qjmed.oxfordjournals.org/content/96/9/635.full http://www.ncbi.nlm.nih.gov/pubmed/15784664
?C0039231	ENSP00000289753	related to serotonin syndrome	http://qjmed.oxfordjournals.org/content/96/9/635.full http://www.ncbi.nlm.nih.gov/pubmed/15784664
C0039231	ENSP00000369237@inh	Norepinephrine transporter-deficient mice exhibit excessive tachycardia http://www.ncbi.nlm.nih.gov/pubmed/15337696
C0039231	ENSP00000369960@inh	Increased heart rate has been observed in ADRA2A mutant mice
C0041582	ENSP00000354612	Inhibition of COX-1 has been linked to GI adverse effects	http://www.ncbi.nlm.nih.gov/pubmed/19680014
C0042024	ENSP00000276198	antagonism of serotonin and adrenergic receptors have been implicated in urinary incontinence http://www.ncbi.nlm.nih.gov/pubmed/15302566
C0042024	ENSP00000276198@inh	antagonism of serotonin and adrenergic receptors have been implicated in urinary incontinence http://www.ncbi.nlm.nih.gov/pubmed/15302566
C0042024	ENSP00000387281@inh	antagonism of serotonin and adrenergic receptors have been implicated in urinary incontinence http://www.ncbi.nlm.nih.gov/pubmed/15302566
C0042024	ENSP00000369960@inh	antagonism of serotonin and adrenergic receptors have been implicated in urinary incontinence http://www.ncbi.nlm.nih.gov/pubmed/15302566
C0042384	ENSP00000356438@inh	vasculitis has been associated with COX2 inhibitors http://www.ncbi.nlm.nih.gov/pubmed/11897288 , and PTG2 mutant mice show other inflammation phenotypes
C0080274	ENSP00000255380	muscarinic antagonists are used to treat bladder hyperactivity	http://www.ncbi.nlm.nih.gov/pubmed/11264473
C0080274	ENSP00000306490	muscarinic antagonists are used to treat bladder hyperactivity	http://www.ncbi.nlm.nih.gov/pubmed/11264473
C0085602	ENSP00000306129@inh	polydipsia is a symptom of the observed phenotype: abnormal adrenal gland physiology
C0085602	ENSP00000289753@inh	polydipsia is a symptom of the observed phenotype: abnormal adrenal gland physiology
C0085631	ENSP00000358301@act	opposite of calming effect of beta blockers
C0085631	ENSP00000305372@act	opposite of calming effect of beta blockers
C0085631	ENSP00000343782@act	opposite of calming effect of beta blockers
C0085631	ENSP00000313661@act	known to influence locomotor activation 	http://www.ncbi.nlm.nih.gov/pubmed/8815958
C0085682	ENSP00000380280@inh	hypophosphatemia occurs in FGF23 mutant mice, i.e. when a ligand of FGFR is absent. receptor inhibition should cause the same phenotype; FGFR1 mutant mice display bone abnormalities
C0149931	ENSP00000206249@act	"Epidemiological, pathophysiological, and clinical evidence link estrogen to migraine headaches"	http://www.ncbi.nlm.nih.gov/pubmed/16622144
C0151744	ENSP00000316244@act	serotonin 1 rec. antagonists cause hypercontraction of coronary arteries	http://www.ncbi.nlm.nih.gov/pubmed/11238275
C0151744	ENSP00000358963	serotonin 1B rec. cause hypercontraction of coronary arteries	http://www.ncbi.nlm.nih.gov/pubmed/11238275
C0151908	ENSP00000337825	tyrosine kinase inhibitors are known to cause dry skin http://www.ncbi.nlm.nih.gov/pubmed/17457301
C0162529	ENSP00000316244@act	HTR1 activation causes vasospasm (which is part of the drug mechanism of action), but this can lead to ischemia	http://sideeffects.embl.de/labels/2003_-_03Oct_PI_-_Amerge_PI/C0162529/
C0220870	ENSP00000265572@act	opioids are known to cause dizziness and lightheadedness	http://books.google.com/books?id=az8uSDkB0mgC&lpg=PA273&ots=fdL2bLbo7-&dq=opioid%20receptor%20dizziness&pg=PA273#v=onepage&q=n%20cause%20sedation,%20confusion,%20dizziness,%20and%20euphoria.&f=false
C0235660	ENSP00000354859@inh	linked to remove of dopaminergic prolactin inhibition http://books.google.com/books?id=vOQqyNhTDl0C&lpg=PA895&ots=LqXPl2j5_1&dq=gynecomastia%20dopamine&pg=PA896#v=onepage&q=gynecomastia%20dopamine&f=false http://www.ncbi.nlm.nih.gov/pubmed/11739329
C0428977	ENSP00000358301@inh	beta blockers are known to slow heart rate and lead to bradycardia	http://www.ncbi.nlm.nih.gov/pubmed/11334782
C0428977	ENSP00000358301	beta blockers are known to slow heart rate and lead to bradycardia	http://www.ncbi.nlm.nih.gov/pubmed/11334782
C0428977	ENSP00000305372@inh	beta blockers are known to slow heart rate and lead to bradycardia	http://www.ncbi.nlm.nih.gov/pubmed/11334782
C0428977	ENSP00000305372	beta blockers are known to slow heart rate and lead to bradycardia	http://www.ncbi.nlm.nih.gov/pubmed/11334782
C0428977	ENSP00000343782@inh	beta blockers are known to slow heart rate and lead to bradycardia	http://www.ncbi.nlm.nih.gov/pubmed/11334782
C0476089	ENSP00000206249	endometrial carcinoma is linked to excessive estrogen concentrations http://www.ncbi.nlm.nih.gov/pubmed/1186789
C0476089	ENSP00000343925	endometrial carcinoma is linked to excessive estrogen concentrations http://www.ncbi.nlm.nih.gov/pubmed/1186789
C0476089	ENSP00000206249@act	endometrial carcinoma is linked to excessive estrogen concentrations http://www.ncbi.nlm.nih.gov/pubmed/1186789
C0476089	ENSP00000343925@act	endometrial carcinoma is linked to excessive estrogen concentrations http://www.ncbi.nlm.nih.gov/pubmed/1186789
C0497247	ENSP00000358301@act	converse of hypotension caused by beta blockers
C0497247	ENSP00000305372@act	converse of hypotension caused by beta blockers
C0497247	ENSP00000343782@act	converse of hypotension caused by beta blockers
C0497247	ENSP00000369237	Norepinephrine transporter-deficient mice exhibit elevated blood pressure http://www.ncbi.nlm.nih.gov/pubmed/15337696
C0575081	ENSP00000261707@inh	mutations in the serotonergic system lead to abnormal gait in mice	http://www.ncbi.nlm.nih.gov/pubmed/7984037
C0575081	ENSP00000328968@inh	abnormal gait is a phenotype of SCN8A mutant mice
C0686347	ENSP00000373169@inh ENSP00000176183@inh ENSP00000373169@inh ENSP00000327652@inh	known to be linked to dopamine antagonists	http://www.ncbi.nlm.nih.gov/pubmed/10881961
C0241442	ENSP00000373169@inh ENSP00000176183@inh ENSP00000373169@inh ENSP00000327652@inh	as symptom of tardive dyskinaesia, which is known to be linked to dopamine antagonists	http://www.ncbi.nlm.nih.gov/pubmed/10881961
C0699893	ENSP00000371138	RNA-mediated suppression of Fkbp1a increases tumor cell invasion http://www.ncbi.nlm.nih.gov/pubmed/14612567
C0040264	ENSP00000356438 ENSP00000354612@inh ENSP00000356438@inh	cyclooxygenases are expressed in the ear http://www.ncbi.nlm.nih.gov/pubmed/15668527 and have been implicated in ototoxicity http://www.ncbi.nlm.nih.gov/pubmed/12736364
C1384666	ENSP00000356438 ENSP00000354612@inh ENSP00000356438@inh	cyclooxygenases are expressed in the ear http://www.ncbi.nlm.nih.gov/pubmed/15668527 and have been implicated in ototoxicity http://www.ncbi.nlm.nih.gov/pubmed/12736364
C1510472	ENSP00000394624@act	drug dependence to opiates is well-known
~C0003534	ENSP00000359793	part of the indication
~C0011570	ENSP00000234961	text-mining error: "respiratory depression", not "mental depression"
~C0027051	ENSP00000358963@act	false positive due to identical warnings on triptan labels
~C0027051	ENSP00000313661@act	false positive due to identical warnings on triptan labels
~C0027121	ENSP00000273430@inh	false positive due to identical warnings on sartan labels
~C0038525	ENSP00000322924@act	false positive due to identical warnings on triptan labels
~C0042510	ENSP00000358963@act	false positive due to identical warnings on triptan labels
~C0042510	ENSP00000313661@act	false positive due to identical warnings on triptan labels
~C0042514	ENSP00000358963@act	false positive due to identical warnings on triptan labels
~C0042514	ENSP00000313661@act	false positive due to identical warnings on triptan labels
~C0151744	ENSP00000358963@act	false positive due to identical warnings on triptan labels
~C0151744	ENSP00000313661@act	false positive due to identical warnings on triptan labels
~C0151786	ENSP00000273430@inh	false positive due to identical warnings on sartan labels
~C0684343	ENSP00000359793	part of the indication
~C0236036	ENSP00000358301@inh ENSP00000305372 ENSP00000358301 ENSP00000305372@inh ENSP00000343782	labels state for many beta blockers that this side effect has not been observed
